Stay updated on Elranatamab vs Lenalidomide Post-Transplant Clinical Trial
Sign up to get notified when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.

Latest updates to the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page
- Check4 days agoChange DetectedThe page has been updated to reflect new dates and changes in the terminology regarding minimal residual disease rates, with a specific focus on the sustained MRD negative rate. Additionally, the name of the organization has been slightly modified.SummaryDifference3%
- Check11 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.5%
- Check18 days agoChange DetectedThe page has updated the revision number from v2.16.2 to v2.16.3 and corrected the formatting of the name 'American Oncology Partners, P.A.' to 'American Oncology Partners, P.A. Dba MidAmerica Cancer Care'.SummaryDifference0.4%
- Check26 days agoChange DetectedThe page has updated the status of American Oncology Partners, P.A. dba MidAmerica Cancer Care from 'Recruiting' to 'Terminated', indicating a significant change in their operational status. Additionally, the revision number has been updated from v2.16.1 to v2.16.2.SummaryDifference0.2%
- Check33 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with a revision update from v2.16.0 to v2.16.1.SummaryDifference0.7%
- Check40 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
Stay in the know with updates to Elranatamab vs Lenalidomide Post-Transplant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Elranatamab vs Lenalidomide Post-Transplant Clinical Trial page.